Publications by authors named "David J Lederer"

Claim this Profile
A
Association of obstructive sleep apnea with soluble biomarkers of lung and vascular injury: the multi-ethnic study of atherosclerosis.
Daniel J Gottlieb, Spencer L Hansen, Robyn L McClelland, Elaine Cornell, John S Kim, David J Lederer

Sleep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma.
Ian D Pavord, Klaus F Rabe, Elliot Israel, Stanley J Szefler, Guy Brusselle, David J Lederer

J Allergy Clin Immunol Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE).
Jorge F Maspero, Martti A Antila, Antoine Deschildre, Leonard B Bacharier, Arman Altincatal, David J Lederer

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics.
Jorge F Maspero, Alessandro G Fiocchi, Antoine Deschildre, Leonard B Bacharier, Arman Altincatal, David J Lederer

J Allergy Clin Immunol Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.
Klaus F Rabe, Fernando J Martinez, Surya P Bhatt, Tomotaka Kawayama, Borja G Cosio, David J Lederer

ERJ Open Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.
Leonard B Bacharier, Ian D Pavord, Jorge F Maspero, Daniel J Jackson, Alessandro G Fiocchi, David J Lederer

J Allergy Clin Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study.
Leonard B Bacharier, Theresa W Guilbert, Constance H Katelaris, Antoine Deschildre, Wanda Phipatanakul, David J Lederer

J Allergy Clin Immunol Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
Alberto Papi, Mario Castro, Jonathan Corren, Ian D Pavord, Yuji Tohda, David J Lederer

Respir Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study.
Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, David J Lederer

Lancet Respir Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.
Ian D Pavord, Arnaud Bourdin, Alberto Papi, Christian Domingo, Jonathan Corren, David J Lederer

Allergy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Alessandro G Fiocchi, Wanda Phipatanakul, Robert S Zeiger, Sandy R Durrani, Jeremy Cole, David J Lederer

Eur Respir J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
Jonathan Corren, Nicola A Hanania, William W Busse, Lawrence D Sher, Arman Altincatal, David J Lederer

Clin Exp Allergy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and Reproducibility of Automated Measurement of Body Composition: A Lung Transplant Body Composition Cohort Study.
Michaela R Anderson, Joshua Diamond, Michael Shashaty, Jonathan P Singer, Yubing Tong, David J Lederer

Ann Am Thorac Soc· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Nikolaos G Papadopoulos, Stanley J Szefler, Leonard B Bacharier, Jorge F Maspero, Christian Domingo, David J Lederer

Allergy· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Lung Transplant Frailty Scale (LT-FS).
Jonathan P Singer, Jason D Christie, Joshua M Diamond, Michaela A Anderson, Luke A Benvenuto, David J Lederer

J Heart Lung Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
Daniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, Lawrence Sher, Christian Domingo, David J Lederer

Ann Allergy Asthma Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of interstitial lung abnormalities: the MESA Lung Study.
Claire F McGroder, Spencer Hansen, Karen Hinckley Stukovsky, David Zhang, P Hrudaya Nath, David J Lederer

Eur Respir J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subphenotypes of frailty in lung transplant candidates.
Jonathan P Singer, Carolyn S Calfee, Kevin Delucchi, Joshua M Diamond, Michaela A Anderson, David J Lederer

Am J Transplant· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
Nicola A Hanania, Mario Castro, Eric Bateman, Ian D Pavord, Alberto Papi, David J Lederer

Ann Allergy Asthma Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
Sumathi Sivapalasingam, David J Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of positive airway pressure therapy of obstructive sleep apnea on circulating Angiopoietin-2.
Daniel J Gottlieb, David J Lederer, John S Kim, Russell P Tracy, Su Gao

Sleep Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry.
Michail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, David J Lederer, Cheilonda Johnson

Rheumatology (Oxford)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.
Lawrence D Sher, Michael E Wechsler, Klaus F Rabe, Jorge F Maspero, Nadia Daizadeh, David J Lederer

Chest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities.
John S Kim, Gísli Thor Axelsson, Matthew Moll, Michaela R Anderson, Elana J Bernstein, David J Lederer

Am J Respir Crit Care Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon, David J Lederer

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis